These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8534185

  • 1. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
    Tanaka Y, Ohmori Y, Toki T, Okazaki Y, Ogoshi S, Ogawa Y.
    Nihon Geka Hokan; 1995 Jan 01; 64(1):15-22. PubMed ID: 8534185
    [Abstract] [Full Text] [Related]

  • 2. Multiple cutaneous metastases from male breast carcinoma.
    Karakuzu A, Koc M, Ozdemir S.
    J Am Acad Dermatol; 2006 Dec 01; 55(6):1101-2. PubMed ID: 17097408
    [Abstract] [Full Text] [Related]

  • 3. [A case of inflammatory breast cancer treated with preoperative intra-arterial infusion chemotherapy].
    Migita T, Shiiba K, Saito Y, Shibata C, Matsuno S.
    Gan To Kagaku Ryoho; 1994 Dec 01; 21(16):2825-8. PubMed ID: 7993122
    [Abstract] [Full Text] [Related]

  • 4. [A case of giant advanced breast cancer responding remarkably to CEFT therapy].
    Yano M, Kume K, Ono E, Wakasugi K, Matsuzaka T, Fujinaga H.
    Gan To Kagaku Ryoho; 1993 Jun 01; 20(8):1067-70. PubMed ID: 8512336
    [Abstract] [Full Text] [Related]

  • 5. [A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer].
    Feng J, Zheng X, Dai A.
    Zhonghua Zhong Liu Za Zhi; 1998 Nov 01; 20(6):468-70. PubMed ID: 10920949
    [Abstract] [Full Text] [Related]

  • 6. Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
    Di Lauro L, Vici P, Del Medico P, Laudadio L, Tomao S, Giannarelli D, Pizzuti L, Sergi D, Barba M, Maugeri-Saccà M.
    Breast Cancer Res Treat; 2013 Aug 01; 141(1):119-23. PubMed ID: 23982884
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A case of far advanced breast cancer with distant metastases which had mostly disappeared after chemoendocrine therapy].
    Nishimura H, Takasuna K, Kondo R, Hayashi K, Munakata Y, Kasuga Y.
    Gan To Kagaku Ryoho; 2000 May 01; 27(5):753-7. PubMed ID: 10832447
    [Abstract] [Full Text] [Related]

  • 13. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
    Ogawa Y, Nishioka A, Inomata T, Hamada N, Terashima M, Yoshida S, Tanaka Y, Ogoshi S, Araki K, Kumon M.
    Radiat Med; 1994 May 01; 12(1):29-35. PubMed ID: 8016401
    [Abstract] [Full Text] [Related]

  • 14. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
    Satoh Y, Une Y, Fujisawa J, Uchino J.
    Gan To Kagaku Ryoho; 1994 Oct 01; 21(14):2509-12. PubMed ID: 7944500
    [Abstract] [Full Text] [Related]

  • 15. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
    Andreadis C, Charalampidou M, Diamantopoulos N, Chouchos N, Mouratidou D.
    Gynecol Oncol; 2004 Oct 01; 95(1):252-5. PubMed ID: 15385141
    [Abstract] [Full Text] [Related]

  • 16. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM, GEICAM 9906 Study Investigators.
    J Natl Cancer Inst; 2008 Jun 04; 100(11):805-14. PubMed ID: 18505968
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
    Battelli N, Massacesi C, Braconi C, Pilone A, Manzione L, Dinota A, Cobelli S, Scanni A, Sturba F, Giacomini G, Morale D, Giorgi F, Tummarello D, Cascinu S.
    Am J Clin Oncol; 2006 Aug 04; 29(4):380-4. PubMed ID: 16891866
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
    Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P.
    Br J Cancer; 2000 Dec 04; 83(11):1480-7. PubMed ID: 11076657
    [Abstract] [Full Text] [Related]

  • 20. [A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia].
    Terazaki Y, Nagamatsu H, Ono H, Iwakuma N, Shirouzu K.
    Gan To Kagaku Ryoho; 2005 May 04; 32(5):675-7. PubMed ID: 15918571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.